Pages that link to "Q28367249"
Jump to navigation
Jump to search
The following pages link to Pulmonary hypertension and fenfluramine (Q28367249):
Displaying 50 items.
- Appetite suppressants and primary pulmonary hypertension in the United Kingdom (Q24563207) (← links)
- Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome (Q26776222) (← links)
- DNA Damage and Pulmonary Hypertension (Q27005594) (← links)
- Fenfluramine--induced irreversible pulmonary hypertension (Q28325081) (← links)
- Current ideas on the treatment of obesity (Q28337250) (← links)
- Irreversible pulmonary hypertension after treatment with fenfluramine (Q28360666) (← links)
- Primary pulmonary hypertension and fenfluramine use (Q28378428) (← links)
- Dietary pulmonary hypertension (Q33789022) (← links)
- Obesity drugs and the heart (Q33802744) (← links)
- Risk factors for pulmonary arterial hypertension. (Q34094102) (← links)
- Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene (Q34142690) (← links)
- Advance modern medicine with clinical case reports (Q34633837) (← links)
- Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction (Q34913082) (← links)
- Anorectic drugs and vascular disease: the role of voltage-gated K+ channels (Q34961826) (← links)
- Pulmonary hypertension, sleep-disordered breathing, and beta blockers in heart failure patients (Q35043904) (← links)
- Myocardial infarction associated with the use of dextrofenfluramine (Q35170281) (← links)
- Pulmonary hypertension as a result of drug therapy (Q35737059) (← links)
- Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome (Q36245909) (← links)
- Safety of drug therapies used for weight loss and treatment of obesity (Q36433990) (← links)
- How to write a patient case report (Q36600823) (← links)
- Management of primary pulmonary hypertension (Q36754872) (← links)
- Pulmonary arterial hypertension: an overview (Q36834617) (← links)
- Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance (Q37012882) (← links)
- Epidemiology of pulmonary hypertension in the elderly (Q37670921) (← links)
- Pulmonary veno-occlusive disease: advances in clinical management and treatments (Q37867672) (← links)
- Primary pulmonary hypertension: diagnosis, medical and surgical treatment (Q37969678) (← links)
- Stimulants and the lung : review of literature (Q38113985) (← links)
- Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population (Q38681023) (← links)
- Insulin resistance in systemic hypertension: pharmacotherapeutic implications (Q40949586) (← links)
- Pulmonary hypertension in chronic liver disease (Q41006417) (← links)
- Dexfenfluramine. An updated review of its therapeutic use in the management of obesity (Q41445495) (← links)
- Respiratory toxicities from stimulant use. (Q41634311) (← links)
- A close look at fenfluramine and dexfenfluramine (Q41738934) (← links)
- Effective medical writing: How to write a case report which Editors would publish (Q42348300) (← links)
- Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension (Q42537756) (← links)
- High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine (Q42545031) (← links)
- Pulmonary hypertension and dexfenfluramine (Q42566646) (← links)
- 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats (Q44264971) (← links)
- Systolic pulmonary artery pressure and serum uric acid levels in patients with hyperthyroidism (Q44327115) (← links)
- Determining exposure underreporting in pharmacoepidemiologic case-control studies: methods and example (Q44620193) (← links)
- Reversible pulmonary hypertension associated with anorexigen use (Q44670274) (← links)
- Scleroderma after therapy with appetite suppressants. Report on four cases (Q45083333) (← links)
- Systolic pulmonary artery pressure and echocardiographic measurements in patients with euthyroid Hashimoto's thyroiditis. (Q45993720) (← links)
- DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS. (Q50124360) (← links)
- Irreversible pulmonary hypertension after treatment with fenfluramine. (Q55174440) (← links)
- Irreversible pulmonary hypertension after treatment with fenfluramine (Q70298196) (← links)
- Primary pulmonary hypertension (Q70319872) (← links)
- An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain (Q71688950) (← links)
- Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath (Q72841171) (← links)
- Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure (Q92106417) (← links)